Natixis Increases Stock Holdings in Cardinal Health, Inc. (NYSE:CAH)

Natixis boosted its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 294.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 108,527 shares of the company's stock after buying an additional 81,023 shares during the period. Natixis' holdings in Cardinal Health were worth $12,835,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in CAH. Cyrus J. Lawrence LLC purchased a new position in shares of Cardinal Health in the fourth quarter valued at $26,000. Promus Capital LLC purchased a new position in shares of Cardinal Health in the 4th quarter worth $30,000. Lee Danner & Bass Inc. bought a new stake in shares of Cardinal Health in the 4th quarter worth about $35,000. Kentucky Trust Co bought a new stake in shares of Cardinal Health in the 4th quarter worth about $41,000. Finally, HHM Wealth Advisors LLC raised its position in shares of Cardinal Health by 57.6% during the 4th quarter. HHM Wealth Advisors LLC now owns 394 shares of the company's stock valued at $47,000 after buying an additional 144 shares in the last quarter. Hedge funds and other institutional investors own 87.17% of the company's stock.

Analysts Set New Price Targets

CAH has been the topic of several analyst reports. Wells Fargo & Company boosted their price objective on Cardinal Health from $135.00 to $136.00 and gave the stock an "equal weight" rating in a research note on Tuesday, February 4th. Jefferies Financial Group raised Cardinal Health from a "hold" rating to a "buy" rating and boosted their target price for the company from $140.00 to $150.00 in a research report on Wednesday, February 5th. Citigroup raised their price target on Cardinal Health from $120.00 to $129.00 and gave the stock a "neutral" rating in a research report on Friday, January 10th. JPMorgan Chase & Co. raised their target price on shares of Cardinal Health from $142.00 to $145.00 and gave the stock a "neutral" rating in a report on Tuesday, February 4th. Finally, Bank of America upped their price target on shares of Cardinal Health from $150.00 to $155.00 and gave the company a "buy" rating in a report on Friday, April 11th. Four analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $140.86.

Cardinal Health Trading Up 1.1 %

Shares of CAH traded up $1.42 during mid-day trading on Thursday, hitting $135.85. The company's stock had a trading volume of 1,588,006 shares, compared to its average volume of 2,183,954. The firm has a market capitalization of $32.82 billion, a price-to-earnings ratio of 25.35, a PEG ratio of 1.49 and a beta of 0.61. The company's 50-day moving average is $130.40 and its 200-day moving average is $123.61. Cardinal Health, Inc. has a 52-week low of $93.17 and a 52-week high of $139.50.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. As a group, sell-side analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st were given a $0.5056 dividend. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.49%. The ex-dividend date was Tuesday, April 1st. Cardinal Health's payout ratio is currently 37.69%.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.